Furosemide Injection 20mg/2ml for Effective Heart Failure Treatment

• Customization: Available
• Application: Internal Medicine
• Usage Mode: For external use
• Model NO.: AMC14012-02
• Suitable for: Elderly, Children, Adult
• State: Liquid
• Shape: Liquid
• Type: Biological Products
• Pharmaceutical Technology: Chemical Synthesis
• Packing: 20mg/2ml, 10′s/Box, 200boxes/CTN
• CTN Size: 40.5*30.5*32cm
• OEM/ODM: Support
• Transport: Shipping
• Transport Package: 10′s/Box
• Specification: 20mg/2ml
• Trademark: Medipharm or OEM
• Origin: China
• HS Code: 3004909099
• Production Capacity: 100000ctns/Month

Product Description

Furosemide Injection

Name	Furosemide Injection
Specidication	20mg/2ml, 10's/box, 200boxes/ctn
Ctn Size	40.5*30.5*32cm
Brand	Medipharm or OEM
Origin	China

Indications:
1. Edematous diseases include congestive heart failure, cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons), especially when other diuretic drugs are not effective, the use of this class of drugs may still be effective. Combined with other drugs to treat acute pulmonary edema and acute cerebral edema.
2. Hypertension In the stepped therapy of hypertension, it is not the first choice for the treatment of essential hypertension, but when the efficacy of thiazide drugs is not good, especially when accompanied by renal insufficiency or hypertensive crisis, this class of drugs is especially suitable.
3. Prevention of acute renal failure is used for renal blood perfusion insufficiency caused by various reasons, such as water loss, shock, poisoning, anesthesia accidents and circulatory insufficiency, etc. Timely application while correcting insufficient blood volume can reduce the chance of acute tubular necrosis.
4. Hyperkalemia and hypercalcemia.
5. Dilutive hyponatremia, especially when the blood sodium concentration is below 120mmol/L.
6. Hyperdiuretic hormone secretion (SIADH).
7. Acute drug poisonings such as barbiturates.
Contra-indications:
It is commonly associated with water and electrolyte disorders, especially in large doses or long-term application, such as postural hypotension, shock, hypokalemia, hypochloremia, hypochloremic alkalosis, hyponatremia, hypocalcemia, and related thirst, fatigue, muscle soreness, arrhythmia, etc. In rare cases, there are allergic reactions (including rash, interstitium nephritis, and even cardiac arrest), blurred vision, xanthopia, light sensitivity, dizziness, headache, poor appetite, nausea, vomiting, abdominal pain, diarrhea, pancreatitis, muscular rigidity, etc., skeletal inhibition leading to granulocytopenia, thrombocytopenic purpura and aplastic anemia, liver function impairment, and digital (digital) paresthesia, etc. Hyperglycemia, positive urine sugar, aggravation of existing diabetes, hyperuricemia. Tinnitus and hearing impairment are more common when a large dose of rapid intravenous injection (dose greater than 4 to 15mg per minute), most of them are temporary, and a few are irreversible, especially when used with other ototoxic drugs. In hypercalcemia, it can cause kidney stones. It has also been reported that this drug can aggravate idiopathic edema.
Precautions & Warning:
(1) Cross allergy. People who are allergic to sulfanilamide and thiazide diuretic drugs may also be allergic to this drug.
(2) Interference with diagnosis: it can cause elevated blood sugar and positive urine sugar, especially in patients with diabetes or pre-diabetes. Excessive dehydration can temporarily increase blood uric acid and urea nitrogen levels. Blood concentrations of Na+, Cl-, K+, Ca2+ and Mg2+ decreased.
(3) Use with caution in the following cases: no urine or serious renal damage, the latter because of the need to increase the dose, so the medication interval should be extended to avoid ototoxicity and other side effects; Diabetes mellitus; Hyperuricemia or history of gout; Hepatic coma can be induced by water and electrolyte disorder in patients with severe liver function impairment; Acute myocardial infarction, excessive diuresis can induce shock; Pancreatitis or history of this; There is a tendency of hypokalemia, especially the use of digitalis drugs or ventricular arrhythmia; Lupus erythematosus, this drug can aggravate the condition or induce activity; Hypertrophy of prostate.
(4) Follow-up examination: blood electrolytes, especially those with digitalis drugs or corticosteroids, liver and kidney function impairment; Blood pressure, especially for blood pressure, large dose applications or for the elderly; Kidney function; Liver function; Blood sugar; blood uric acid; acid-base balance; Listening.
(5) The drug dose should start from the minimum effective dose, and then adjust the dose according to the diuretic response to reduce the occurrence of side effects such as water and electrolyte disturbances.
(6) parenteral medication should be given intravenously, and intramuscular injection should not be advocated. The intravenous injection time of conventional dose should be more than 1 to 2 minutes, and the intravenous injection of large dose should not exceed 4mg per minute. The same effect can be achieved at 1/2 of the intravenous dose.
(7) This medicine is a sodium salt injection made of alkali, which is relatively alkaline, so it should be diluted with sodium chloride injection for intravenous injection, rather than with glucose injection.
(8) When there is hypokalemia or a tendency to hypokalemia, attention should be paid to supplementing potassium salt.
(9) When combined with antihypertensive drugs, the dose of the latter should be adjusted as appropriate.
(10) Patients with oliguria or anuria should stop taking the drug if the maximum dose remains ineffective 24 hours after application.
(11) Athletes use with caution.
Storage instructions:
Store below 25ºC. Protect from moisture. Keep out of reach of children.

--------------------------------------------------------------------------------------------------